Talkspace (TALK) Competitors $2.50 +0.04 (+1.63%) Closing price 04:00 PM EasternExtended Trading$2.51 +0.01 (+0.40%) As of 04:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TALK vs. NHC, VRDN, AVAH, AHCO, TDOC, GRAL, PNTG, CDNA, FLGT, and FTREShould you be buying Talkspace stock or one of its competitors? The main competitors of Talkspace include National HealthCare (NHC), Viridian Therapeutics (VRDN), Aveanna Healthcare (AVAH), AdaptHealth (AHCO), Teladoc Health (TDOC), GRAIL (GRAL), The Pennant Group (PNTG), CareDx (CDNA), Fulgent Genetics (FLGT), and Fortrea (FTRE). These companies are all part of the "healthcare" industry. Talkspace vs. Its Competitors National HealthCare Viridian Therapeutics Aveanna Healthcare AdaptHealth Teladoc Health GRAIL The Pennant Group CareDx Fulgent Genetics Fortrea Talkspace (NASDAQ:TALK) and National HealthCare (NYSE:NHC) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, media sentiment, earnings, risk and institutional ownership. Do institutionals and insiders have more ownership in TALK or NHC? 57.4% of Talkspace shares are held by institutional investors. Comparatively, 56.4% of National HealthCare shares are held by institutional investors. 23.5% of Talkspace shares are held by company insiders. Comparatively, 15.0% of National HealthCare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has better earnings and valuation, TALK or NHC? National HealthCare has higher revenue and earnings than Talkspace. National HealthCare is trading at a lower price-to-earnings ratio than Talkspace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTalkspace$187.59M2.23$1.15M$0.02125.00National HealthCare$1.37B1.21$66.80M$6.7116.02 Do analysts recommend TALK or NHC? Talkspace presently has a consensus target price of $4.50, suggesting a potential upside of 80.00%. Given Talkspace's stronger consensus rating and higher probable upside, equities analysts clearly believe Talkspace is more favorable than National HealthCare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Talkspace 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.00National HealthCare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is TALK or NHC more profitable? National HealthCare has a net margin of 10.03% compared to Talkspace's net margin of 1.41%. National HealthCare's return on equity of 6.87% beat Talkspace's return on equity.Company Net Margins Return on Equity Return on Assets Talkspace1.41% 2.47% 2.09% National HealthCare 10.03%6.87%4.68% Which has more risk & volatility, TALK or NHC? Talkspace has a beta of 1.06, indicating that its share price is 6% more volatile than the S&P 500. Comparatively, National HealthCare has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Does the media prefer TALK or NHC? In the previous week, Talkspace had 16 more articles in the media than National HealthCare. MarketBeat recorded 20 mentions for Talkspace and 4 mentions for National HealthCare. National HealthCare's average media sentiment score of 0.70 beat Talkspace's score of 0.11 indicating that National HealthCare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Talkspace 4 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral National HealthCare 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryTalkspace beats National HealthCare on 10 of the 17 factors compared between the two stocks. Get Talkspace News Delivered to You Automatically Sign up to receive the latest news and ratings for TALK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TALK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TALK vs. The Competition Export to ExcelMetricTalkspaceMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$418.30M$1.97B$5.51B$9.83BDividend YieldN/AN/A4.59%4.13%P/E Ratio125.0633.9530.0325.33Price / Sales2.239.44447.53104.15Price / Cash210.4251.2424.8128.01Price / Book3.629.858.715.87Net Income$1.15M-$62.35M$3.26B$265.22M7 Day Performance10.13%-0.55%0.90%1.13%1 Month Performance-5.30%-2.54%3.65%2.45%1 Year Performance49.70%28.93%46.29%27.99% Talkspace Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TALKTalkspace3.8113 of 5 stars$2.50+1.6%$4.50+80.0%+45.6%$418.30M$187.59M125.06500Earnings ReportAnalyst RevisionNHCNational HealthCareN/A$103.43+3.0%N/A-15.8%$1.60B$1.37B12.9612,400Dividend AnnouncementVRDNViridian Therapeutics1.833 of 5 stars$16.89+2.9%$37.00+119.1%+12.5%$1.34B$300K-4.4150Trending NewsEarnings ReportAnalyst RevisionAVAHAveanna Healthcare1.1841 of 5 stars$6.83+11.2%$6.10-10.7%+45.0%$1.28B$2.02B85.3833,500News CoverageAnalyst UpgradeAHCOAdaptHealth3.9673 of 5 stars$9.33+1.5%$13.40+43.6%-1.0%$1.24B$3.26B17.2810,500Analyst UpgradeTDOCTeladoc Health2.9641 of 5 stars$6.79-2.5%$9.76+43.9%-5.1%$1.23B$2.57B-5.705,500GRALGRAIL1.2603 of 5 stars$32.69-0.4%$31.50-3.6%+102.3%$1.18B$125.60M-0.541,360PNTGThe Pennant Group3.4475 of 5 stars$26.15+0.6%$33.80+29.3%-13.7%$898.61M$695.24M33.537,000Analyst UpgradeCDNACareDx4.1333 of 5 stars$11.77-1.7%$27.67+135.1%-56.5%$637.13M$333.79M11.54740Earnings ReportFLGTFulgent Genetics3.6807 of 5 stars$20.61+1.2%$25.33+22.9%-13.8%$623.20M$283.47M-12.421,313FTREFortrea3.995 of 5 stars$6.39-2.9%$14.00+119.1%-74.6%$597.46M$2.70B-0.5615,500Earnings ReportInsider TradeAnalyst RevisionGap Up Related Companies and Tools Related Companies National HealthCare Competitors Viridian Therapeutics Competitors Aveanna Healthcare Competitors AdaptHealth Competitors Teladoc Health Competitors GRAIL Competitors The Pennant Group Competitors CareDx Competitors Fulgent Genetics Competitors Fortrea Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TALK) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredElon Musk: “Nothing happens without this…”Lithium has fueled the EV boom, but another resource is even more critical. Without it, over 20 million electr...Behind the Markets | SponsoredTurn your "dead money" into $306+ monthly (starting this month)Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...Investors Alley | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talkspace, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talkspace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access